Who receives chemotherapy: An analysis of stage IV prostate cancer (PCa) patients in SEER-Medicare

被引：0
|
作者：
Grabner, M.
Onukwugha, E.
Mullins, C. D.
Seal, B. S.
Hussain, A.
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA
[3] Sanofi Aventis, Bridgewater, NJ USA
[4] Univ Maryland, Ctr Canc, Baltimore, MD 21201 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.4655
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4655
引用
收藏
页数：1
相关论文
共 50 条
  • [1] INITIAL COSTS OF TREATMENT AMONG STAGE IV PROSTATE CANCER (PCA) CHEMOTHERAPY PATIENTS IN SEER-MEDICARE
    Onukwugha, E.
    Mullins, C. D.
    Seal, B.
    Hussain, A.
    VALUE IN HEALTH, 2010, 13 (03) : A31 - A31
  • [2] PHYSICIAN REFERRAL PATTERNS AMONG ELDERLY PATIENTS WITH STAGE IV PROSTATE CANCER (PCA): AN ANALYSIS USING SEER-MEDICARE DATA
    Onukwugha, E. E.
    Mullins, C. D.
    Seal, B.
    Hussain, A.
    VALUE IN HEALTH, 2009, 12 (03) : A54 - A55
  • [3] Radiation oncologist visits and the effect on prostate cancer (PCa) survival among SEER-Medicare patients with stage IV disease.
    Onukwugha, E.
    Mullins, C. D.
    Grabner, M.
    Hussain, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Patterns of use of docetaxel in stage IV prostate cancer (PCa) patients in SEER-Medicare.
    Onukwugha, E.
    Grabner, M.
    Mullins, C. D.
    Seal, B. S.
    Hussain, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] TIMING OF PHYSICIAN VISITS AND THE IMPACT ON SURVIVAL AMONG SEER-MEDICARE PATIENTS WITH STAGE IV PROSTATE CANCER
    Onukwugha, E. E.
    Mullins, C. D.
    Seal, B.
    Hussain, A.
    VALUE IN HEALTH, 2009, 12 (03) : A38 - A38
  • [6] Characteristics of stage III and IV M0 prostate cancer (PCa) patients in SEER-Medicare who develop bone metastasis (BM) following diagnosis.
    Hussain, Arif
    Onukwugha, Ebere
    Jayasekera, Jinani
    McNally, Diane L.
    Seal, Brian S.
    Mullins, C. Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Use of Bevacizumab for Elderly Patients With Stage IV Colon Cancer: Analysis of SEER-Medicare Data
    Raab, Gabriel T.
    Lin, Aijing
    Hillyer, Grace Clarke
    Keller, Deborah
    O'Neil, Daniel S.
    Accordino, Melissa Kate
    Buono, Donna L.
    Hur, Chin
    Kiran, Ravi P.
    Wright, Jason D.
    Hershman, Dawn L.
    Neugut, Alfred I.
    CLINICAL COLORECTAL CANCER, 2019, 18 (03) : E294 - E299
  • [8] Frequency of Unplanned Surgery in Patients with Stage IV Colorectal Cancer Receiving Palliative Chemotherapy with an Intact Primary: An Analysis of SEER-Medicare
    Lorimer, P. D.
    Motz, B. M.
    Kirks, R. C.
    Han, Y.
    Hwang, J. J.
    Salo, J. C.
    Hill, J. S.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S36 - S36
  • [9] Frequency of unplanned surgery in patients with stage IV colorectal cancer receiving palliative chemotherapy with an intact primary: An analysis of SEER-Medicare
    Lorimer, Patrick D.
    Motz, Benjamin M.
    Kirks, Russell C.
    Han, Yimei
    Symanowski, James T.
    Hwang, Jimmy J.
    Salo, Jonathan C.
    Hill, Joshua S.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (03) : 407 - 414
  • [10] FOLFOX and FOLFIRI Use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data
    Neugut, Alfred I.
    Lin, Aijing
    Raab, Gabriel T.
    Hillyer, Grace Clarke
    Keller, Deborah
    O'Neil, Daniel S.
    Accordino, Melissa Kate
    Kiran, Ravi P.
    Wright, Jason
    Hershman, Dawn L.
    CLINICAL COLORECTAL CANCER, 2019, 18 (02) : 133 - 140
12345